Brought to you by 
Biofrontera Pharma grosses $11.5mm in private placement
10 Jun 2003
Executive Summary
Biofrontera Pharmaceuticals (drug discovery for nervous system disorders. Alzheimer's and Parkinson's diseases, and schizophrenia) grossed $11.5mm (DM23mm) in an oversubscribed private placement led by 3i Group Investments, which was joined by Alta Vista Equity Partner GMBH, TRE Holding, and Technologie BG der Deutschen Ausgleichsbank. Investors in the company's first round of financing, LeVenture KB and TechnoMedia KB, also participated.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Biofrontera Pharma grosses $11.5mm in private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice